Ta-Jen Wu

Synthetic Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Increases Plasma Levels of Adiponectin in Type 2 Diabetic Patients

Wei‐Shiung Yang, Chi-Yuan Jeng, Ta-Jen Wu et al. · Diabetes Care · 2002 · 405 citations · Full text

Studies on the microspheres comprised of reconstituted collagen and hydroxyapatite

Ta-Jen Wu, Hsiu-Hsuan Huang, Cheng-Wen Lan et al. · Biomaterials · 2003 · 131 citations

Tissue Engineering, Regenerative Medicine, Reconstituted Collagen +10

Epidemiologic study of type 2 diabetes in Taiwan

Chih‐Jen Chang, Feng‐Hwa Lu, Yi‐Ching Yang et al. · Diabetes Research and Clinical Practice · 2000 · 106 citations

Obesity, Diabetes Epidemiology, Diabetes +4

Prevalence and Risk Factors of Diabetic Retinopathy Among Noninsulin-dependent Diabetic Subjects

Muh‐Shy Chen, Chie-Shung Kao, Chih‐Jen Chang et al. · American Journal of Ophthalmology · 1992 · 105 citations

Diabetic Retinopathy, Diabetes Epidemiology, Ophthalmology +7

Efficacy and safety of exenatide in patients of Asian descent with type 2 diabetes inadequately controlled with metformin or metformin and a sulphonylurea

Yan Gao, Kun‐Ho Yoon, Lee‐Ming Chuang et al. · Diabetes Research and Clinical Practice · 2008 · 88 citations

Metabolic Syndrome, Diabetes Management, Asian Descent +7